Susquehanna International Group’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331K | Sell |
127,272
-4,225
| -3% | -$11K | ﹤0.01% | 4903 |
|
|
2025
Q1 | $250K | Buy |
131,497
+76,882
| +141% | +$146K | ﹤0.01% | 5260 |
|
|
2024
Q4 | $79.2K | Buy |
54,615
+18,578
| +52% | +$26.9K | ﹤0.01% | 5750 |
|
|
2024
Q3 | $66.3K | Sell |
36,037
-14,418
| -29% | -$26.5K | ﹤0.01% | 5231 |
|
|
2024
Q2 | $50.5K | Buy |
+50,455
| New | +$50.5K | ﹤0.01% | 5275 |
|
|
2024
Q1 | – | Sell |
-65,852
| Closed | -$103K | – | 5697 |
|
|
2023
Q4 | $103K | Buy |
+65,852
| New | +$103K | ﹤0.01% | 5337 |
|
|
2023
Q3 | – | Sell |
-25,507
| Closed | -$81.1K | – | 5661 |
|
|
2023
Q2 | $81.1K | Sell |
25,507
-757,110
| -97% | -$2.41M | ﹤0.01% | 5083 |
|
|
2023
Q1 | $2.56M | Buy |
782,617
+326,936
| +72% | +$1.07M | ﹤0.01% | 1702 |
|
|
2022
Q4 | $2.29M | Buy |
455,681
+435,943
| +2,209% | +$2.19M | ﹤0.01% | 1490 |
|
|
2022
Q3 | $45K | Buy |
+19,738
| New | +$45K | ﹤0.01% | 5525 |
|